WCTC has a formal policy regarding the need for authors and presenters to inform Annual Meeting attendees of any potential Conflict of Interest (COI). A COI includes, but is not limited to, employment, ownership of stock, membership on a standing advisory council or committee, or being on the board of directors or publicly associated with a company or its products. Other potential areas of real or perceived conflict of interest could include receiving honoraria, consulting fees, or grants.
Baek, Jung Hwan
Consultant: Financial activites not related to the present lecture: Consultant of two radiofrequency companies, STARmed and RF Medical since 2017
Grants: (To University) Exelixis, Bayer, Loxo, Lilly, Blueprint. Consultant: Exelixis, Bayer, Lilly, Blueprint
Other Financials: I received an advisory board fee from EISAI and from Lilly.
Research Support: Merck and Eisai (to my institution)
Research Support: Bayer, Merck, Novartis, Kura Oncology, Ayala Pharma, AstraZeneca, Elevar Therapeutics, BMS. Stock Shareholder: Inxmed, Rgenta, Affyiummune, Eisai, Exelixis
Hodak, Steven P.
Speakers Bureau: StarMed Medical, Taewoon Medical
Consultant: Starmed, Taewong.
Other Financials: Lilly and EISAI: Advisory Boards
Grants: Eisai Pharmaceuticals, Loxo/Lilly Pharmaceuticals, Blueprint Pharmaceuticals, Exelixis, MJH Life Sciences.
Other Financials: Dr. Nikiforov and his spouse have IP ownership and receive royalties related to Thyroseq from the University of Pittsburgh. They both also have a consultancy agreement with Sonic Healthcare USA.
Consultant: IBSA – Lugano (Switzerland) – consulting fees
Grants: Eisai Research Clinical Trial Grant
Speakers Bureau: RF Medical, Alpha Surgical.
Consultant: Eisai, Eli Lilly
Consultant: Baxter Scientific
Research Support: Eli Lilly and Merck.
Sosa, Julie Ann
Research Support: Institutional research funding was received from Exelixis and Eli Lilly. Other Financials: Member, Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry supported by GlaxoSmithKline, Novo Nordisk, Astra Zeneca and Eli Lilly.
Consultant: Medtronic, RGS Healthcare, Pulse Biosciences.
Consultant: Bayer Healthcare, Blueprint Medicines, Eli Lilly, Eisai, Exelixis, Merck.
Consultant: Sanofi Genzyme, GlaxoSmithKline, Medtronic Canada, Proteocyte Diagnostics Inc. Stock Shareholder: Proteocyte Diagnostics Inc.
Research Support: Principal Investigator Clinical Trails supported by Merck and Eli Lilly.